4.8 Article

Canonical Wnt signaling negatively regulates platelet function

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0906268106

关键词

Wnt-beta-catenin pathway; integrin alpha IIb beta 3; frizzled 6 knockout mice

资金

  1. Health Research Board of Ireland [RP/2006/286]
  2. Irish Research Council for Science, Engineering, and Technology [PD/2008/33]
  3. Higher Education Authority of Ireland
  4. British Heart Foundation [RG/05/015, PG/07/118/24152, PG/08/049/25130]
  5. Biotechnology and Biological Sciences Research Council Research Development Fellowship
  6. National Institutes of Health [1R01HL093179, GM078172]
  7. March of Dimes
  8. NSF [0544061]
  9. Health Research Board (HRB) [PD-2008-33] Funding Source: Health Research Board (HRB)
  10. Direct For Biological Sciences
  11. Division Of Integrative Organismal Systems [0544061] Funding Source: National Science Foundation
  12. British Heart Foundation [PG/08/049/25130] Funding Source: researchfish

向作者/读者索取更多资源

Wnts regulate important intracellular signaling events, and dysregulation of the Wnt pathway has been linked to human disease. Here, we uncover numerous Wnt canonical effectors in human platelets where Wnts, their receptors, and downstream signaling components have not been previously described. We demonstrate that the Wnt3a ligand inhibits platelet adhesion, activation, dense granule secretion, and aggregation. Wnt3a also altered platelet shape change and inhibited the activation of the small GTPase RhoA. In addition, we found the Wnt-beta-catenin signaling pathway to be functional in platelets. Finally, disruption of the Wnt Frizzled 6 receptor in the mouse resulted in a hyperactivatory platelet phenotype and a reduced sensitivity to Wnt3a. Taken together our studies reveal a novel functional role for Wnt signaling in regulating anucleate platelet function and may provide a tractable target for future antiplatelet therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pediatrics

The role of the calibrated automated thrombogram in neonates: describing mechanisms of neonatal haemostasis and evaluating haemostatic drugs

Claire A. Murphy, Elaine Neary, Daniel P. O'Reilly, Sarah Cullivan, Afif El-Khuffash, Fionnuala NiAinle, Patricia B. Maguire, Naomi McCallion, Barry Kevane

Summary: The evaluation of haemostasis is particularly challenging in neonates due to their limited blood volume. The Calibrated Automated Thrombogram (CAT) has successfully elucidated several differences between haemostatic mechanisms in premature and term neonates compared with adults. However, the lack of evidence of CAT as an accurate predictor of neonatal bleeding, blood volume required, and the absence of an evidence-based treatment algorithm for abnormal CAT results limit its current application as a bedside clinical tool for the evaluation of sick neonates.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

Article Cardiac & Cardiovascular Systems

Epigenetic Regulation of F2RL3 Associates With Myocardial Infarction and Platelet Function

Laura J. Corbin, Stephen J. White, Amy E. Taylor, Christopher M. Williams, Kurt Taylor, Marion T. van den Bosch, Jack E. Teasdale, Matthew Jones, Mark Bond, Matthew T. Harper, Louise Falk, Alix Groom, Georgina G. J. Hazell, Lavinia Paternoster, Marcus R. Munafo, Borge G. Nordestgaard, Anne Tybjaerg-Hansen, Stig E. Bojesen, Caroline Relton, Josine L. Min, George Davey Smith, Andrew D. Mumford, Alastair W. Poole, Nicholas J. Timpson

Summary: Epigenetic DNA hypomethylation at the F2RL3 gene induced by smoking may increase PAR4 expression, leading to downstream effects on platelet reactivity. F2RL3 DNA methylation may be a possible contributory pathway from smoking to cardiovascular disease risk.

CIRCULATION RESEARCH (2022)

Article Hematology

Maintaining flippase activity in procoagulant platelets is a novel approach to reducing thrombin generation

Sarah L. Millington-Burgess, Matthew T. Harper

Summary: The study revealed that R5421 can reduce platelet PS exposure and inhibit thrombin generation by maintaining flippase activity in procoagulant platelets, without directly inhibiting scramblase activity.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis

Sarah Kelliher, Luisa Weiss, Sarah Cullivan, Ellen O'Rourke, Claire A. Murphy, Shane Toolan, Aine Lennon, Paulina B. Szklanna, Shane P. Comer, Hayley Macleod, Ana Le Chevillier, Sean Gaine, Kate M. A. O'Reilly, Brian McCullagh, John Stack, Patricia B. Maguire, Fionnuala Ni Ainle, Barry Kevane

Summary: A study found that patients with moderate COVID-19 exhibited increased hypercoagulability and endothelial damage despite receiving thromboprophylaxis, which may have clinical implications.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Cell Biology

Q94 is not a selective modulator of proteinase-activated receptor 1 (PAR1) in platelets

Luc R. A. Francis, Sarah L. Millington-Burgess, Taufiq Rahman, Matthew T. Harper

Summary: Thrombin activates platelets through PAR1 and PAR4, with PAR1 being the more rapidly activated receptor. Q94, an allosteric modulator of PAR1, has been reported to inhibit PAR1-G alpha q coupling in various cell lines, but its effects on human platelet activation have not been studied. Our data suggest that Q94 may have off-target effects in platelets independent of PAR1, precluding its use as a selective PAR1 allosteric modulator.

PLATELETS (2022)

Article Multidisciplinary Sciences

Endothelial inflammation and neutrophil transmigration are modulated by extracellular matrix composition in an inflammation-on-a-chip model

Rebecca B. Riddle, Karin Jennbacken, Kenny M. Hansson, Matthew T. Harper

Summary: Inflammatory diseases are characterized by excessive neutrophil infiltration, but lack of accurate in vitro and in vivo models hinders drug development. This study developed a 3D in vitro inflammation-on-a-chip model to mimic neutrophil migration across endothelium and extracellular matrix. The composition of the extracellular matrix was found to significantly affect neutrophil transmigration and response to inhibitors, providing potential for disease-specific drug development.

SCIENTIFIC REPORTS (2022)

Article Oncology

Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells

Annalisa Contursi, Rosa Fullone, Paulina Szklanna-Koszalinska, Simone Marcone, Paola Lanuti, Francesco Taus, Alessandra Meneguzzi, Giulia Turri, Melania Dovizio, Annalisa Bruno, Corrado Pedrazzani, Stefania Tacconelli, Marco Marchisio, Patrizia Ballerini, Pietro Minuz, Patricia Maguire, Paola Patrignani

Summary: This study aimed to investigate the release of EVs from activated platelets in CRC patients and healthy controls and their effect on gene expression and lipid mediator synthesis. The protein content of thrombin-stimulated mEVs was found to be modulated in CRC and could potentially serve as a noninvasive tool to discriminate patients from healthy subjects. Furthermore, the interaction between platelet mEVs and cancer cells may provide valuable prognostic information and aid in the development of targeted anticancer strategies.

CANCERS (2023)

Letter Hematology

Platelet procoagulant membrane dynamics: a key distinction between thrombosis and hemostasis?

Ejaife O. Agbani, Ingeborg Hers, Alastair W. Poole

BLOOD ADVANCES (2023)

Letter Hematology

Chemical degradation of BTK/TEC as a novel approach to inhibit platelet function

Justin S. Trory, Attila Munkacsi, Kamila M. Sledz, Jordan Vautrinot, Lucy J. Goudswaard, Molly L. Jackson, Kate J. Heesom, Samantha F. Moore, Alastair W. Poole, Behnam Nabet, Varinder K. Aggarwal, Ingeborg Hers

BLOOD ADVANCES (2023)

Article Multidisciplinary Sciences

Human soluble CD39 displays substrate inhibition in a substrate-specific manner

Venkat M. K. Vadlamani, Kavinda K. J. Gunasinghe, Xavier W. Chee, Taufiq Rahman, Matthew T. Harper

Summary: CD39 is a key regulator that metabolizes extracellular ATP and ADP to AMP. This study demonstrates that soluble, recombinant CD39 exhibits substrate inhibition with ADP or ATP as the substrate. High concentrations of ATP or ADP significantly reduce CD39 activity. In contrast, inhibition is not observed with UDP or UTP as substrates. Understanding the substrate inhibition of CD39 is important for interpreting CD39 activity studies and investigations into drugs modulating CD39 activity.

SCIENTIFIC REPORTS (2023)

Article Multidisciplinary Sciences

Highly efficient platelet generation in lung vasculature reproduced by microfluidics

Xiaojuan Zhao, Dominic Alibhai, Tony G. Walsh, Nathalie Tarassova, Maximilian Englert, Semra Z. Birol, Yong Li, Christopher M. Williams, Chris R. Neal, Philipp Burkard, Stephen J. Cross, Elizabeth W. Aitken, Amie K. Waller, Jose Ballester Beltran, Peter W. Gunning, Edna C. Hardeman, Ejaife O. Agbani, Bernhard Nieswandt, Ingeborg Hers, Cedric Ghevaert, Alastair W. Poole

Summary: Perfusion of megakaryocytes through the mouse lung vasculature generates a large number of functional platelets. This study reveals the mechanisms of thrombopoiesis in lung vasculature and provides insights for large-scale platelet generation.

NATURE COMMUNICATIONS (2023)

Article Hematology

Consensus report on markers to distinguish procoagulant platelets from apoptotic platelets: communication from the Scientific and Standardization Committee of the ISTH

Emma C. Josefsson, Sofia Ramstrom, Johannes Thaler, Marie Lordkipanidze, COAGAPO Study Grp

Summary: The study aimed to identify a set of markers and/or methods to detect and distinguish procoagulant platelets from apoptotic platelets. Using flow cytometry, a combination of three surface markers, including P-selectin (CD62P), phosphatidylserine (recognized by annexin V), and platelet-specific receptor GPIX (CD42a) or αIIb integrin (CD41, GPIIb), was recommended for differentiation. Procoagulant platelets are positive for all three markers, while apoptotic platelets are positive for annexin V and platelet-specific surface receptor(s) but negative for P-selectin.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Article Hematology

Alterations in platelet proteome signature and impaired platelet integrin & alpha;IIb & beta;3 activation in patients with COVID-19

Lucy J. Goudswaard, Christopher M. Williams, Jawad Khalil, Kate L. Burley, Fergus Hamilton, David Arnold, Alice Milne, Phil A. Lewis, Kate J. Heesom, Stuart J. Mundell, Andrew D. Davidson, Alastair W. Poole, Ingeborg Hers

Summary: Patients with COVID-19 have altered platelet function, which is associated with increased risk of thrombosis. Platelet protein expression is different in COVID-19 patients, and platelet functional responses are reduced. Platelets in COVID-19 patients also show increased association with neutrophils. These findings suggest that platelet-driven thromboinflammation may contribute to the increased risk of thrombosis in COVID-19 patients.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Article Hematology

Protease-activated receptor antagonists prevent thrombosis when dual antiplatelet therapy is insufficient in an occlusive thrombosis microfluidic model

Jess Berry, Matthew T. Harper

Summary: This study investigated the potential of protease-activated receptor (PAR) antagonists to prevent occlusive thrombosis under conditions where dual antiplatelet therapy (DAPT) is insufficient. The results showed that DAPT had limited efficacy when tissue factor (TF) was present, but combining DAPT with PAR antagonism was effective in preventing occlusive thrombosis.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

暂无数据